| High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study J Helms, C Tacquard, F Severac, I Leonard-Lorant, M Ohana, ... Intensive care medicine 46 (6), 1089-1098, 2020 | 3218 | 2020 |
| Neurologic features in severe SARS-CoV-2 infection J Helms, S Kremer, H Merdji, R Clere-Jehl, M Schenck, C Kummerlen, ... New England Journal of Medicine 382 (23), 2268-2270, 2020 | 3151 | 2020 |
| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Nature 596 (7871), 276-280, 2021 | 2176 | 2021 |
| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 748 | 2021 |
| Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study S Choquet, V Leblond, R Herbrecht, G Socié, AM Stoppa, ... Blood 107 (8), 3053-3057, 2006 | 501 | 2006 |
| Brain MRI findings in severe COVID-19: a retrospective observational study S Kremer, F Lersy, J De Sèze, JC Ferré, A Maamar, B Carsin-Nicol, ... Radiology 297 (2), E242-E251, 2020 | 477 | 2020 |
| Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses I Benotmane, G Gautier, P Perrin, J Olagne, N Cognard, S Fafi-Kremer, ... Jama 326 (11), 1063-1065, 2021 | 374 | 2021 |
| Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients J Helms, S Kremer, H Merdji, M Schenck, F Severac, R Clere-Jehl, ... Critical care 24, 1-11, 2020 | 354 | 2020 |
| Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France F Gallais, A Velay, C Nazon, MJ Wendling, M Partisani, J Sibilia, ... Emerging infectious diseases 27 (1), 113, 2021 | 283 | 2021 |
| An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants S Caillard, D Anglicheau, M Matignon, A Durrbach, C Greze, L Frimat, ... Kidney international 98 (6), 1549-1558, 2020 | 272 | 2020 |
| Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study S Kremer, F Lersy, M Anheim, H Merdji, M Schenck, H Oesterle, ... Neurology 95 (13), e1868-e1882, 2020 | 257 | 2020 |
| Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies MB Zeisel, I Fofana, S Fafi-Kremer, TF Baumert Journal of hepatology 54 (3), 566-576, 2011 | 250 | 2011 |
| Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth L Sentilhes, F De Marcillac, C Jouffrieau, P Kuhn, V Thuet, Y Hansmann, ... American journal of obstetrics and gynecology 223 (6), 914. e1-914. e15, 2020 | 232 | 2020 |
| Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine I Benotmane, G Gautier-Vargas, N Cognard, J Olagne, F Heibel, ... Kidney international 99 (6), 1498-1500, 2021 | 207 | 2021 |
| Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis S Fafi-Kremer, P Morand, JP Brion, P Pavese, M Baccard, R Germi, ... The Journal of infectious diseases 191 (6), 985-989, 2005 | 199 | 2005 |
| Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes I Fofana, SE Krieger, F Grunert, S Glauben, F Xiao, S Fafi–Kremer, ... Gastroenterology 139 (3), 953-964. e4, 2010 | 198 | 2010 |
| Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection F Gallais, P Gantner, T Bruel, A Velay, D Planas, MJ Wendling, S Bayer, ... EBioMedicine 71, 2021 | 194 | 2021 |
| Drug-resistant cytomegalovirus in transplant recipients: a French cohort study S Hantz, F Garnier-Geoffroy, MC Mazeron, I Garrigue, P Merville, ... Journal of antimicrobial chemotherapy 65 (12), 2628-2640, 2010 | 171 | 2010 |
| Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients I Benotmane, G Gautier-Vargas, N Cognard, J Olagne, F Heibel, ... Kidney international 99 (6), 1487-1489, 2021 | 165 | 2021 |
| Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation S Fafi-Kremer, I Fofana, E Soulier, P Carolla, P Meuleman, ... Journal of Experimental Medicine 207 (9), 2019-2031, 2010 | 165 | 2010 |
